Thank to this community - started in may 2022. 5 percent min 2 times daily - 0.5 fin daily - 1.5 mm dermaroller weekly. Started with 1mm deramaroller at start. Progress Pictures 7/1/2024
A user shared their hair loss treatment progress, using 5% Minoxidil twice daily, 0.5 mg Finasteride daily, and a 1.5 mm dermaroller weekly. They started with a 1 mm dermaroller in May 2022.
View this post in the Community →
Similar Community Posts Join
6 / 6 resultscommunity 2.5 years on fin + min – regrowth, shedding phases, LLLT stabilized
The user experienced regrowth and stabilization in hair density using finasteride, minoxidil, a derma roller, and an LLLT helmet, but noticed a recent decline in hair quality. They only take finasteride orally and are unsure about the effectiveness of the LLLT device.
community 1 year and 5 months progress oral fin + topical min
User shared progress on hair regrowth using 1.25 mg finasteride daily, 5% minoxidil, and a 1.5 mm dermaroller twice a week, with no side effects. Users discussed shedding phases, application methods, and the necessity of continuous treatment to maintain results.
community I started thing on the crown after 3 months on fin - M19
A 19-year-old is experiencing crown thinning after three months on finasteride and minoxidil, hoping it's just a shedding phase. They also use a dermaroller weekly and seek hair regrowth and stabilization.
community Day 1 vs 6 months vs 1 year vs 2 years. Finasteride, minoxidil and derma rolling.
A user documented their two-year hair regrowth journey using finasteride, minoxidil, and derma rolling, showing significant improvement. They switched from topical to oral minoxidil after the first year, experiencing some shedding and minor bloating.
community 6 months on minoxidil shedding again
The user has been using topical minoxidil for 10 months and oral finasteride for 3 months, reporting significant hair regrowth. They also use a dermaroller weekly and have experienced no side effects from finasteride.
community 20 year old male 4 month progress on 2.5min, 1mg fin, 1.5mm derma stamp.
A 20-year-old male experienced significant hair regrowth and reduced shedding after four months of using 2.5mg oral minoxidil, 1mg oral finasteride, and weekly 1.5mm derma stamping. He reported no side effects from the treatments and noted increased hair growth in other areas of his body.
Related Research
6 / 6 resultsresearch Combination and rotational therapy in androgenetic alopecia
This review proposes a combination treatment scheme with a rotational approach for managing androgenetic alopecia, drawing on evidence for effectiveness, long-term use convenience, and patient acceptance, but presents no new clinical results.
research Safety concerns when using novel medications to treat alopecia
This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.
research Managing patterned hair loss – a hair raising task!
This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
research Status of research on the development and regeneration of hair follicles
This review examines the mechanisms of hair follicle development and regeneration, discussing current hair loss treatments and emerging therapies like low-level laser therapy and stem cell therapy, which the authors suggest show promise in managing hair loss.
research Hair Restoration in Androgenetic Alopecia: Looking Beyond Minoxidil, Finasteride and Hair Transplantation
This review discusses the emerging pathophysiological factors and potential new therapies for androgenetic alopecia beyond traditional treatments, but reports no new results.
research Female Androgenetic Alopecia: An Update on Diagnosis and Management
This review discusses female androgenetic alopecia, highlighting its diagnostic challenges and management strategies, but it reports no new results.